 | • レポートコード：QYR2104Z1112 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、心臓バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トロポニン、CK-MB、ナトリウム利尿ペプチド-BNP・NT-proBNP、ミオグロビン、その他）、用途別市場規模（急性冠症候群、心筋梗塞、うっ血性心不全、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・心臓バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・心臓バイオマーカーの種類別市場規模（トロポニン、CK-MB、ナトリウム利尿ペプチド-BNP・NT-proBNP、ミオグロビン、その他） ・心臓バイオマーカーの用途別市場規模（急性冠症候群、心筋梗塞、うっ血性心不全、その他） ・心臓バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・心臓バイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・心臓バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心臓バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・心臓バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Abbott、F. Hoffmann-La Roche、Advanced ImmunoChemical、AgPlus Diagnostics、BG Medicine、BioLegend、bioMérieux、Bio-Rad Laboratories、BODITECH MED） ・結論 |
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.
Market Analysis and Insights: Global Cardiac Biomarkers Market
The global Cardiac Biomarkers market size is projected to reach US$ 1315.7 million by 2026, from US$ 704.2 million in 2019, at a CAGR of 9.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiac Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiac Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiac Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiac Biomarkers market.
Global Cardiac Biomarkers Scope and Market Size
Cardiac Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Troponin
CK-MB
Natriuretic Peptides – BNP and NT-proBNP
Myoglobin
Others
Segment by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Abbott
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Natriuretic Peptides – BNP and NT-proBNP
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Coronary Syndrome
1.3.3 Myocardial Infarction
1.3.4 Congestive Heart Failure
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Biomarkers Market Perspective (2016-2027)
2.2 Cardiac Biomarkers Growth Trends by Regions
2.2.1 Cardiac Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiac Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Cardiac Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Cardiac Biomarkers Industry Dynamic
2.3.1 Cardiac Biomarkers Market Trends
2.3.2 Cardiac Biomarkers Market Drivers
2.3.3 Cardiac Biomarkers Market Challenges
2.3.4 Cardiac Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Biomarkers Players by Revenue
3.1.1 Global Top Cardiac Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Cardiac Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Cardiac Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiac Biomarkers Revenue
3.4 Global Cardiac Biomarkers Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Revenue in 2020
3.5 Cardiac Biomarkers Key Players Head office and Area Served
3.6 Key Players Cardiac Biomarkers Product Solution and Service
3.7 Date of Enter into Cardiac Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Biomarkers Breakdown Data by Type
4.1 Global Cardiac Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Cardiac Biomarkers Forecasted Market Size by Type (2022-2027)
5 Cardiac Biomarkers Breakdown Data by Application
5.1 Global Cardiac Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Cardiac Biomarkers Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cardiac Biomarkers Market Size (2016-2027)
6.2 North America Cardiac Biomarkers Market Size by Type
6.2.1 North America Cardiac Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Cardiac Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Cardiac Biomarkers Market Size by Type (2016-2027)
6.3 North America Cardiac Biomarkers Market Size by Application
6.3.1 North America Cardiac Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Cardiac Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Cardiac Biomarkers Market Size by Application (2016-2027)
6.4 North America Cardiac Biomarkers Market Size by Country
6.4.1 North America Cardiac Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Cardiac Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cardiac Biomarkers Market Size (2016-2027)
7.2 Europe Cardiac Biomarkers Market Size by Type
7.2.1 Europe Cardiac Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Cardiac Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Cardiac Biomarkers Market Size by Type (2016-2027)
7.3 Europe Cardiac Biomarkers Market Size by Application
7.3.1 Europe Cardiac Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Cardiac Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Cardiac Biomarkers Market Size by Application (2016-2027)
7.4 Europe Cardiac Biomarkers Market Size by Country
7.4.1 Europe Cardiac Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Cardiac Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Cardiac Biomarkers Market Size by Type
8.2.1 Asia-Pacific Cardiac Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiac Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiac Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiac Biomarkers Market Size by Application
8.3.1 Asia-Pacific Cardiac Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiac Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiac Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiac Biomarkers Market Size by Region
8.4.1 Asia-Pacific Cardiac Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiac Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cardiac Biomarkers Market Size (2016-2027)
9.2 Latin America Cardiac Biomarkers Market Size by Type
9.2.1 Latin America Cardiac Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Cardiac Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Cardiac Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Cardiac Biomarkers Market Size by Application
9.3.1 Latin America Cardiac Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Cardiac Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Cardiac Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Cardiac Biomarkers Market Size by Country
9.4.1 Latin America Cardiac Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Cardiac Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Cardiac Biomarkers Market Size by Type
10.2.1 Middle East & Africa Cardiac Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiac Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiac Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiac Biomarkers Market Size by Application
10.3.1 Middle East & Africa Cardiac Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiac Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiac Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiac Biomarkers Market Size by Country
10.4.1 Middle East & Africa Cardiac Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiac Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cardiac Biomarkers Introduction
11.1.4 Abbott Revenue in Cardiac Biomarkers Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Cardiac Biomarkers Introduction
11.2.4 Abbott Revenue in Cardiac Biomarkers Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Cardiac Biomarkers Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Advanced ImmunoChemical
11.4.1 Advanced ImmunoChemical Company Details
11.4.2 Advanced ImmunoChemical Business Overview
11.4.3 Advanced ImmunoChemical Cardiac Biomarkers Introduction
11.4.4 Advanced ImmunoChemical Revenue in Cardiac Biomarkers Business (2016-2021)
11.4.5 Advanced ImmunoChemical Recent Development
11.5 AgPlus Diagnostics
11.5.1 AgPlus Diagnostics Company Details
11.5.2 AgPlus Diagnostics Business Overview
11.5.3 AgPlus Diagnostics Cardiac Biomarkers Introduction
11.5.4 AgPlus Diagnostics Revenue in Cardiac Biomarkers Business (2016-2021)
11.5.5 AgPlus Diagnostics Recent Development
11.6 BG Medicine
11.6.1 BG Medicine Company Details
11.6.2 BG Medicine Business Overview
11.6.3 BG Medicine Cardiac Biomarkers Introduction
11.6.4 BG Medicine Revenue in Cardiac Biomarkers Business (2016-2021)
11.6.5 BG Medicine Recent Development
11.7 BioLegend
11.7.1 BioLegend Company Details
11.7.2 BioLegend Business Overview
11.7.3 BioLegend Cardiac Biomarkers Introduction
11.7.4 BioLegend Revenue in Cardiac Biomarkers Business (2016-2021)
11.7.5 BioLegend Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Cardiac Biomarkers Introduction
11.8.4 bioMérieux Revenue in Cardiac Biomarkers Business (2016-2021)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cardiac Biomarkers Introduction
11.9.4 Bio-Rad Laboratories Revenue in Cardiac Biomarkers Business (2016-2021)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 BODITECH MED
11.10.1 BODITECH MED Company Details
11.10.2 BODITECH MED Business Overview
11.10.3 BODITECH MED Cardiac Biomarkers Introduction
11.10.4 BODITECH MED Revenue in Cardiac Biomarkers Business (2016-2021)
11.10.5 BODITECH MED Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cardiac Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Troponin
Table 3. Key Players of CK-MB
Table 4. Key Players of Natriuretic Peptides - BNP and NT-proBNP
Table 5. Key Players of Myoglobin
Table 6. Key Players of Others
Table 7. Global Cardiac Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cardiac Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cardiac Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cardiac Biomarkers Market Share by Regions (2016-2021)
Table 11. Global Cardiac Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cardiac Biomarkers Market Share by Regions (2022-2027)
Table 13. Cardiac Biomarkers Market Trends
Table 14. Cardiac Biomarkers Market Drivers
Table 15. Cardiac Biomarkers Market Challenges
Table 16. Cardiac Biomarkers Market Restraints
Table 17. Global Cardiac Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cardiac Biomarkers Market Share by Players (2016-2021)
Table 19. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers as of 2020)
Table 20. Ranking of Global Top Cardiac Biomarkers Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cardiac Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cardiac Biomarkers Product Solution and Service
Table 24. Date of Enter into Cardiac Biomarkers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cardiac Biomarkers Revenue Market Share by Type (2016-2021)
Table 28. Global Cardiac Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cardiac Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cardiac Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cardiac Biomarkers Revenue Market Share by Application (2016-2021)
Table 32. Global Cardiac Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cardiac Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cardiac Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cardiac Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cardiac Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cardiac Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cardiac Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cardiac Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cardiac Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cardiac Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cardiac Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cardiac Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cardiac Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cardiac Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cardiac Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cardiac Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cardiac Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cardiac Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cardiac Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cardiac Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cardiac Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cardiac Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cardiac Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cardiac Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cardiac Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cardiac Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cardiac Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cardiac Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Cardiac Biomarkers Product
Table 67. Abbott Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Abbott Company Details
Table 70. Abbott Business Overview
Table 71. Abbott Cardiac Biomarkers Product
Table 72. Abbott Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 73. Abbott Recent Development
Table 74. F. Hoffmann-La Roche Company Details
Table 75. F. Hoffmann-La Roche Business Overview
Table 76. F. Hoffmann-La Roche Cardiac Biomarkers Product
Table 77. F. Hoffmann-La Roche Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Recent Development
Table 79. Advanced ImmunoChemical Company Details
Table 80. Advanced ImmunoChemical Business Overview
Table 81. Advanced ImmunoChemical Cardiac Biomarkers Product
Table 82. Advanced ImmunoChemical Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 83. Advanced ImmunoChemical Recent Development
Table 84. AgPlus Diagnostics Company Details
Table 85. AgPlus Diagnostics Business Overview
Table 86. AgPlus Diagnostics Cardiac Biomarkers Product
Table 87. AgPlus Diagnostics Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 88. AgPlus Diagnostics Recent Development
Table 89. BG Medicine Company Details
Table 90. BG Medicine Business Overview
Table 91. BG Medicine Cardiac Biomarkers Product
Table 92. BG Medicine Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 93. BG Medicine Recent Development
Table 94. BioLegend Company Details
Table 95. BioLegend Business Overview
Table 96. BioLegend Cardiac Biomarkers Product
Table 97. BioLegend Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 98. BioLegend Recent Development
Table 99. bioMérieux Company Details
Table 100. bioMérieux Business Overview
Table 101. bioMérieux Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 102. bioMérieux Recent Development
Table 103. Bio-Rad Laboratories Company Details
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories Cardiac Biomarkers Product
Table 106. Bio-Rad Laboratories Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 107. Bio-Rad Laboratories Recent Development
Table 108. BODITECH MED Company Details
Table 109. BODITECH MED Business Overview
Table 110. BODITECH MED Cardiac Biomarkers Product
Table 111. BODITECH MED Revenue in Cardiac Biomarkers Business (2016-2021) & (US$ Million)
Table 112. BODITECH MED Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Troponin Features
Figure 3. CK-MB Features
Figure 4. Natriuretic Peptides - BNP and NT-proBNP Features
Figure 5. Myoglobin Features
Figure 6. Others Features
Figure 7. Global Cardiac Biomarkers Market Share by Application: 2020 VS 2027
Figure 8. Acute Coronary Syndrome Case Studies
Figure 9. Myocardial Infarction Case Studies
Figure 10. Congestive Heart Failure Case Studies
Figure 11. Others Case Studies
Figure 12. Cardiac Biomarkers Report Years Considered
Figure 13. Global Cardiac Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Cardiac Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Cardiac Biomarkers Market Share by Regions: 2020 VS 2027
Figure 16. Global Cardiac Biomarkers Market Share by Regions (2022-2027)
Figure 17. Global Cardiac Biomarkers Market Share by Players in 2020
Figure 18. Global Top Cardiac Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Biomarkers as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2020
Figure 20. Global Cardiac Biomarkers Revenue Market Share by Type (2016-2021)
Figure 21. Global Cardiac Biomarkers Revenue Market Share by Type (2022-2027)
Figure 22. North America Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Cardiac Biomarkers Market Share by Type (2016-2027)
Figure 24. North America Cardiac Biomarkers Market Share by Application (2016-2027)
Figure 25. North America Cardiac Biomarkers Market Share by Country (2016-2027)
Figure 26. United States Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cardiac Biomarkers Market Share by Type (2016-2027)
Figure 30. Europe Cardiac Biomarkers Market Share by Application (2016-2027)
Figure 31. Europe Cardiac Biomarkers Market Share by Country (2016-2027)
Figure 32. Germany Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cardiac Biomarkers Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Cardiac Biomarkers Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Cardiac Biomarkers Market Share by Region (2016-2027)
Figure 42. China Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cardiac Biomarkers Market Share by Type (2016-2027)
Figure 50. Latin America Cardiac Biomarkers Market Share by Application (2016-2027)
Figure 51. Latin America Cardiac Biomarkers Market Share by Country (2016-2027)
Figure 52. Mexico Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cardiac Biomarkers Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Cardiac Biomarkers Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Cardiac Biomarkers Market Share by Country (2016-2027)
Figure 58. Turkey Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Cardiac Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 64. Advanced ImmunoChemical Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 65. AgPlus Diagnostics Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 66. BG Medicine Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 67. BioLegend Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 68. bioMérieux Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 70. BODITECH MED Revenue Growth Rate in Cardiac Biomarkers Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のうっ血性心不全用治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medicines for Congestive Heart Failure Market The global Medicines for Congestive Heart Failure market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…- 世界の急性心不全（AHF）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 1398 million by 2026, from US$ 262.2 million in 2019, at a CAGR of 26.8% during 2021-2026. With industry-standard accuracy in ana…
- 世界の心臓用植込み型除細動器市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heart Implantable Device Market The global Heart Implantable Device market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の心臓用植込み型装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heart Implant Device Market The global Heart Implant Device market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界のうっ血性心不全（CHF）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Congestive Heart Failure (CHF) Market The global Congestive Heart Failure (CHF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…